The medical device company from Madison, Wisconsin, said in June it expected to make $1 million this year, and would raise $750,000 to put toward future growth. The company raised $875,000, according to a recent regulatory filing.

The acquisition allows the San Diego-based company to expand its transplant diagnostics business, according to Gen-Probe.GTI develops medical diagnostic assays for the transplantation, blood bank and specialty coagulation markets. Its human leukocyte antigen, or HLA, antibody detection products are already sold by Gen-Probe under the Lifecodes brand, but the company has also commercialized a number of other HLA-related testing products, including serological typing trays, enzyme immunoassays and molecular typing products for donor-recipient matching, according to Gen-Probe.

The Securities & Exchange Commission charges Brett Cohen and David Meyers in an alleged insider trading scheme involving shares of Exact Sciences Corp. and Sequenom Inc. that netted more than $600,000.The federal Securities & Exchange Commission charged a Baltimore business consultant and his uncle in Cleveland of an insider trading scheme that netted the pair [...]

Considering the amount of venture money Minnesota and Wisconsin raised through September, you would assume the states are pretty evenly matched. But numbers are tricky things. First of all, the lion’s share of Wisconsin money came from just two deals. And Minnesota is just beginning to track angel investments — a big deal in Wisconsin.

BioMarin Pharmaceutical Inc. has received orphan drug status for an investigational enzyme replacement therapy to treat Pompe disease that was developed by ZyStor Therapeutics in Milwaukee, Wisconsin. Just two weeks ago, BioMarin bought ZyStor for $22 million in cash.

Steve Burrill is searching for money, this time among rich vacation-goers in northern Wisconsin. The San Francisco-based biotech investor who is trying to create a $250 million investment fund to back the Elk Run BioBusiness Park in Pine Island, Minnesota, also is forming a new angel investment group in the Badger State.Burrill is joining forces with former Wisconsin commerce secretary Dick Leinenkugel to target wealthy individuals and families inhabiting vacation homes in the well-to-do resort area of Vilas County in northern Wisconsin.

Exact Sciences Corp. (NASDAQ: EXAS) filed a shelf registration statement for the sale of up to $150 million in equity, debt and warrants, according to the federal Securities and Exchange Commission.

Madison, Wisconsin, biotechnology company Quincy Bioscience has received an undisclosed “capital infusion” from DaneVest Tech Fund I, an investment group in its hometown. Quincy will used the money to support national sales of its Prevagen Brain Cell Protection dietary supplements, which are supposed to combat memory loss.

Though it’s yet to even get its brain cell protection drug into Phase 1 trials, Quincy Bioscience is far from the typical young biotech on a shoestring budget.For one thing, there’s the Madison, Wisconsin company’s unusual technology. Quincy has patented the use of a jellyfish protein called aequorin to treat disorders that result from excess [...]

Cytometix Inc. has raised $1.9 million in equity to further development of a drug that treats pain, according to a Securities and Exchange Commission filing.The company plans to use the funding to take the drug to the point at which it can file an Investigational New Drug application with federal regulators, CEO Lane Brostrom said. [...]